OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Charles River Associates
Walter Colasante is a vice-president in Charles River Associates’ (CRA’s) Life Sciences Practice.
May 15, 2019
The highly customized nature of cell and gene therapy production means that manufacturing innovations for one therapy may not be easily transferable to others.
March 20, 2019
Think ahead to production requirements when planning strategies in early development of gene and cell therapies.